Intensive glucose therapy improves some markers

04/25/2013 | Healio

Older type 2 diabetes patients who underwent intensive glucose-lowering therapy attained better adiponectin, lipid and triglyceride levels at nine months, a study indicated. However, the intensive therapy did not appear to improve cardiovascular outcomes in patients, researchers reported in Diabetes Care.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC